This video is normally available to paying customers.
You may unlock this video for FREE. Enter your email address for instant access AND to receive ongoing updates and special discounts related to this topic.
Hepatitis C, a liver disease caused by the Hepatitis C virus (HCV), can lead to severe conditions such as inflammation, cirrhosis, or liver cancer. With six main strains, genotypes 1 and 3 are the most prevalent in the UK.
HCV can remain dormant in the body for years, making it challenging to estimate the true number of infections. Approximately 215,000 individuals in the UK are believed to be infected, with a significant number among people who inject drugs.
Symptoms may resemble those of Hepatitis B, including flu-like symptoms, fatigue, and abdominal pain. A definitive diagnosis requires a blood test.
Treatment aims to prevent liver damage and spread of the virus, involving lifestyle adjustments and medication. Treatment duration varies based on the virus strain, with regular monitoring through blood tests.
Treatment can last from 8 to 48 weeks, with the effectiveness dependent on the viral genotype. Although treatment has improved, especially for genotype 1, side effects and concerns during pregnancy necessitate careful management.
Treatment effectiveness varies, and reinfection is possible post-treatment. It's essential to adapt treatment plans based on response and to understand that clearance of the virus does not confer immunity.
Understanding Hepatitis C's complexities, from transmission to treatment, is crucial for managing and preventing this disease. While treatments have advanced, vigilance and tailored care are essential for affected individuals.
